Navigation Links
China Sky One Medical, Inc. Announces Its Successful Participation in the 20th International Medical Instruments and Equipment Exhibition
Date:4/16/2008

HARBIN, China, April 16 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (''China Sky One Medical'' or ''the Company'') (OTC Bulletin Board: CSKI), a leading manufacturer, marketer, and distributor of over-the-counter pharmaceuticals for external use in the People's Republic of China (''PRC'') and international markets, today announced its successful participation in the 20th International Medical Instruments and Equipment Exhibition, which was held in Beijing, China from April 3rd to April 5th 2008.

The International Exhibition, well recognized throughout the industry, has been held for 20 consecutive years with over 600 vendors from about 20 countries. The 2008 Exhibition attracted more than 30,000 visitors from around the world.

This was the third year China Sky One Medical participated in the Exhibition. The Company sponsored a booth at the show for healthcare products & diagnostic kits and was exposed to 150 international distributors, many of whom expressed a strong interest in the Company's products. Its Slim Patch Body-Beauty Plaster product gained significant attention due to its revolutionary technique to reduce weight compared to competitors' products. Two companies, one from Russia and one from the UK expressed their interest in becoming distributors for the Slim Patch Body-Beauty Plaster product and Diagnostic Kits, and are now in discussions with the Company regarding future cooperation and marketing agreements.

''We are excited about the high reception of our products at the exhibition, a good demonstration of our strong brand recognition and product popularity. We intend to continue with our strategy to focus on sales and marketing to increase our international customer base,'' said Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical, Inc.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its sub
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. China RuiTai Reports Fiscal Year 2007 Financial Results
2. MM2 Group Closes Sale for New Venture in China
3. China Yingxia International, Inc. Retains CCG Elite
4. Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics
5. China Medical Technologies to Announce 4QFY2007 Financial Results, Declare Annual Cash Dividend and Provide FY2008 Annual Targets on June 12, 2008
6. Mindray to Exhibit at 2008 China International Medical Equipment Fair
7. China Nepstar Chain Drugstore Awarded Prestigious Title of 2007 Best Drugstore Chain in China by China Drugstore Magazine
8. China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.
9. Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area
10. Mindray to Attend the JPMorgan 4th Annual China Conference
11. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... David Kim of the Live Life Again Center, a practi...e of a growing number of physicians who are takin...connect with individuals who are interested in sur...y. Dr. Kim is utilizing Facebook to share before-a... with the community. , Da...
(Date:11/25/2009)...Newswire-USNewswire/--Whenmostpeopleheartheacronym...ogivepatientsthehelptheyneed.TMJstandsfortheTempor...ntacts/connectswithyourskull(temporalbone). ,, ...repainwithchewing,clickingorpoppingofthejaw.Butman...ng:headaches,fatigue,sleepdisturbances,irritabilit...
(Date:11/25/2009)...wire/-SentinelleMedicalInc.,aleadingmanufacturerof...chesasuiteofnewleadingedgeclinicalapplicationsonit...,sRadiologicalSocietyofNorthAmerica(RSNA)annualmee...heapplicationsleveragetheuniquehighqualityimagesge...supportmultipleimagingmodalitiesformulti-parametri...
(Date:11/25/2009)...RNewswire/--TheBayAreaAirQualityManagementDistrict... Air Alert forThursday,November26,2009whichb...fuel,bothindoorsandoutdoors. ,, "Cold,stillweat...idJackBroadbent,executiveofficeroftheAirDistrict."...irneighborsandfellowcommunitymembersthisThanksgivi...
(Date:11/25/2009)...at grew out of a collaboration between UCLA engine... the nearly 10 million Americans who suffer from p...hardening of the arteries, peripheral arterial dis...hich narrowed arteries reduce blood flow to the li...scular disease, heart attack and stroke, and its p...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4
... by the researchers now reckons the evil effects o... protects against the development of brain tumors ...s done a couple of years ago , an unexpected findi...// The recent study undwells the fact that g...
...al engineering team has announced the development ... person,with an ability to deliver a visual acuity...ature television camera and an ultrasonic distance... processing the video and distance signals,// the ...
...ng history of sorts, doctors in Ohio, the United S...ar vein to a man to rid him of a painful ulcer due...his is the first time a bovine vein is used in man...ceeded very well. Dr. Hugh Beebe, the center's dir...
...chers at the Georgetown University Lombardi cancer...a protein that they say, is responsible for the sp...lled Pa 28 alpha, can also cause the spread of oth... To isolate the protein, Ngaiza and colleagues ...
...test in cardiology is OCT, which expands into Opti...de many cardiologists sit up and take notice and i...oped by Dr. Brett Bouma an assistant professor at ...ound and will allow cardiologists to view the stat...
...reakthrough using gene therapy mouthwash promises ...hwash wards off oral cancer by destroying suspicio...nt. The idea is to attack the pre-cancerous patche...nthusiastic, as the patches have disappeared compl...
Other Medicine News:Health News:Fight oral cancer with gene therapy mouthwash, 2
(Date:11/25/2009)...AccordingtoMillenniumResearchGroup(MRG),theglobala...early$3billionUSmarketfortraumafixationdeviceswill...etherecenteconomicslowdown.MRG,s USMarketsforTraum...highlydynamicoverthenextfiveyears,withcompetitorsi...dsegmentsofthetraumafixationmarket,fuelingmarketgr...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...ery-USMarketTrends&Analysis http://www.report...Market-Trends--Analysis.html ,, TheUSintranasa...euticapplicationsfromthedeliveryofconventionalloca...cdrugs.Thefutureofthetechnologyhingesontotheeffect...
(Date:11/24/2009)...a/--ChindexInternational,Inc.,("Chindex")(Nasdaq: ...n,healthcareproductsandservicesinthePeople,sRepubl...he21stAnnualPiperJaffray,"Unplugged"HealthCareConf...eHotel. , Managementiscurrentlyscheduledtopre...e-on-onemeetingsthroughouttheday.Awebcast,ofthepre...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2EF Johnson Technologies Inc Highlights New Products at APCO 2009 54570 1EF Johnson Technologies Inc Highlights New Products at APCO 2009 54570 2EF Johnson Technologies Inc Highlights New Products at APCO 2009 54570 3Statewide program to improve emergency care for children 54567 1Statewide program to improve emergency care for children 54567 2Scientists take early steps toward mapping epigenetic variability 9583 1Scientists take early steps toward mapping epigenetic variability 9583 2
...udy to Show That Extended,Thromboprophylaxis Reduc... Statistically Significant 44% , PARIS, July 8, 20...ed today the results of the EXCLAIM (EXtended CLin...study, which showed,the benefit of extended prophy... mobility by demonstrating the superiority of 5 we...
...Inc. (NASDAQ:INSM), a ,biopharmaceutical company f...r the treatment of metabolic diseases with unmet,...nt at this,week,s C.E. Unterberg, Towbin (CEUT) Em... City. , The conference, to be held at the Mand...om Tuesday, July 10th through Thursday,July 12th....
Other Medicine Technology:New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 2New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 3New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 4New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 6Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
Ultimum Introducers
Irrigating Cannula Handpiece (Titanium)
Stronger Irrigation/Aspiration Cannula
... are designed for endomyocardial biopsies. The r... of a 3-pull ring handle, stainless steel cutting ...rotates to accommodate any position. ,A spring in...s are opened by moving the double rings away from ...
Medicine Products: